• Home>
  • Stocks>
  • Thyrocare Technologies Ltd Share Price
Thyrocare Technologies Ltd share price logo

Thyrocare Technologies Ltd Share Price

(THYROCARE)

Small Cap

Healthcare Sector

Check the latest share price of Thyrocare Technologies Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹890.25

▲2.4%

as on 04:01PM, 29 Apr 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Thyrocare Technologies Ltd Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹884.05
    Day's Price Range
    ₹919

  • 52 Week's Low

    52 Week's High

    ₹571.4
    52-Week Price Range
    ₹1,055
1 Month Return-2.55 %
3 Month Return-15.06 %
1 Year Return+ 12.08 %
Previous Close₹912.10
Open₹893.15
Volume1.15L
Upper Circuit-
Lower Circuit-
Market Cap₹3,718.29Cr

Thyrocare Technologies Ltd Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹3,718.29 Cr

Return on Equity (ROE)

31.48

Return on capital employed (ROCE)

41.5

P/B Ratio

7.86

Dividend Yield

1.94

EPS (TTM)

33.3

Sector

Healthcare

How to invest in Thyrocare Technologies Ltd

Investing in Thyrocare Technologies Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Thyrocare Technologies Ltd or THYROCARE on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Thyrocare Technologies Ltd or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Thyrocare Technologies Ltd with just a few clicks!

Thyrocare Technologies Ltd Valuation

Track how the P/E of Thyrocare Technologies Ltd has moved over time to understand valuation trends.

Thyrocare Technologies Ltd in the last 5 years

  • Overview

  • Trends

Lowest (18.71x)

June 23, 2022

Today (51.11x)

December 15, 2023

Industry (104.63x)

December 15, 2023

Highest (91.79x)

October 27, 2020

LowHigh

Today’s Price to Earnings Ratio: 51.11x

Analysts Recommendation on Thyrocare Technologies Ltd

Get updated buy, sell, and hold recommendations by analysts on Thyrocare Technologies Ltd.

based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

100% of analysts recommend a 'BUY' rating for Thyrocare Technologies Ltd. Average target of ₹647.5

Source: S&P Global Market Intelligence

Analysts Forecast on Thyrocare Technologies Ltd

Get share price movements and forecasts by analysts on Thyrocare Technologies Ltd.

Thyrocare Technologies Ltd price forecast by 2 analysts

Downside of-7.72%

High

₹650

Target

₹647.50

Low

₹645

Thyrocare Technologies Ltd target price ₹647.5, a slight downside of -7.72% compared to current price of ₹890.25. According to 2 analysts rating.

Source: S&P Global Market Intelligence

Thyrocare Technologies Ltd Financials

Get the annual and quarterly financial summary of Thyrocare Technologies Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹134.89Cr (-)₹148.00Cr (↑9.72%)₹134.74Cr (↓8.96%)₹154.25Cr (↑14.48%)₹156.91Cr (↑1.72%)
Net Income₹17.25Cr (-)₹20.33Cr (↑17.86%)₹14.74Cr (↓27.50%)₹17.18Cr (↑16.55%)₹23.94Cr (↑39.35%)
Net Profit Margin12.79% (-)13.74% (↑7.43%)10.94% (↓20.38%)11.14% (↑1.83%)15.26% (↑36.98%)
Value in ₹ crore
Details2019202020212022
Total Assets₹489.58Cr (-)₹443.38Cr (↓9.44%)₹529.30Cr (↑19.38%)₹597.64Cr (↑12.91%)
Total Liabilities₹33.80Cr (-)₹65.15Cr (↑92.75%)₹83.84Cr (↑28.69%)₹76.94Cr (↓8.23%)
Value in ₹ crore
Details20182019202020212022
Operating Cash Flow₹111.52Cr (-)₹96.56Cr (↓13.41%)₹136.33Cr (↑41.19%)₹111.07Cr (↓18.53%)₹105.68Cr (↓4.85%)

Thyrocare Technologies Ltd Index Inclusions

BSE Healthcare

₹42,555.65

0 (▲0%)

BSE Small-Cap

₹48,193.46

0 (▲0%)

S&P BSE AllCap

₹10,471.31

0 (▲0%)

Thyrocare Technologies Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Thyrocare Technologies Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
71.14%
0.00
Foreign Institutions
10%
0.00
Mutual Funds
7.03%
0.00
Retail Investors
10.41%
0.00
Others
1.42%
0.00

Thyrocare Technologies Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Thyrocare Technologies Ltd with its industry peers.

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Thyrocare Technologies Ltd
Thyrocare Technologies Ltd
BUY₹3,718.29 Cr6.87%0.52NANA
Vijaya Diagnostic Centre Ltd
Vijaya Diagnostic Centre Ltd
BUY₹9,908.51 Cr11.14%0.64NANA
Metropolis Healthcare Ltd
Metropolis Healthcare Ltd
HOLD₹8,213.18 Cr5.46%0.66NANA
Dr Lal Pathlabs Ltd
Dr Lal Pathlabs Ltd
SELL₹22,584.81 Cr16.09%0.63NANA
Laurus Labs Ltd
Laurus Labs Ltd
HOLD₹32,670.61 Cr131.01%0.67NANA
See all

Thyrocare Technologies Ltd News & Key Events

Latest news and events at one place to help you take investing decisions in Thyrocare Technologies Ltd.

  • Thyrocare Reports Strong Q4, Upgraded to BUY - 25 Apr, 2025

    Thyrocare Technologies posted a 24% YoY net profit increase in Q4FY25, with revenue rising 21%. ICICI Securities upgraded the stock to BUY, targeting Rs 1,000.

  • Thyrocare Reports Strong Q4 Earnings and Dividend - 24 Apr, 2025

    Thyrocare Technologies Ltd announced a 22% increase in Q4 net profit to Rs 21.7 crore and a 21.3% rise in revenue to Rs 187.2 crore. The board recommended a final dividend of Rs 21 per share for FY25, reflecting strong operational performance and growth in diagnostic tests.

  • Thyrocare Reports Strong Q4 Results and Dividend - 23 Apr, 2025

    Thyrocare Technologies announced a 21.9% rise in Q4 net profit and a ₹21 dividend. Consolidated net profit increased by 22.05%, with significant revenue growth. Overall, the company demonstrated strong financial performance in Q4 FY25.

  • Thyrocare Confirms SEBI Compliance for Q1 2025 - 08 Apr, 2025

    Thyrocare Technologies Limited has confirmed compliance with SEBI regulations, stating all shares are in dematerialized form with no rematerialization requests for Q1 2025. This ensures transparency and maintains investor confidence.

  • Thyrocare Technologies Announces Trading Window Closure - 27 Mar, 2025

    Thyrocare Technologies Ltd has announced the closure of its trading window from April 1, 2025, until 48 hours after its audited financial results for the fiscal year ending March 31, 2025. This action is in compliance with SEBI regulations on insider trading, ensuring transparency and adherence to regulatory standards.

Insights on Thyrocare Technologies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 12.75% to 12.97% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 11.49% to 11.56% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 19.11 Cr → 21.7 Cr (in ₹), with an average increase of 11.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, THYROCARE stock has moved up by 14.7%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 169.93 Cr → 191.75 Cr (in ₹), with an average increase of 11.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Fortis Healthcare Ltd has given 52.4% return, outperforming this stock by 12.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 71.06% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Max Healthcare Institute Ltd has given 165.8% return, outperforming this stock by 153.3%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.77% to 2.41% in Mar 2025 quarter

About Thyrocare Technologies Ltd

Thyrocare Technologies Limited was incorporated in 2000 and is one of the leading pan-India diagnostic chains, offering 636 distinct tests and 90 profiles of tests for early detection and management of various disorders and diseases. Additionally, they have set up Regional Processing Laboratories (RPLs) in 25 cities and Thryrocare International Holding Company (TIHC) in Mauritius has established a centre in Bahrain. In 2016, Thyrocare Technologies had a public offering that closed with an oversubscription of 75 times, and in 2018 acquired an Associate Company, Equinox Labs Private Limited, as well as bought back 958900 equity shares. In 2020, their services were negatively affected due to the Coronavirus, however, in 2021 they had a new promoter, Docon Technologies Private Limited, acquire 37656092 equity shares of the Company.As of March 31 2022, Thyrocare Technologies had a network of 1500 active channel partners and more than 9000 collection points spread across 500 districts in India and provided an extensive menu of over 700 tests, with more than 300 added within the year. Additionally, they installed automation for urine testing in 12 lab locations and Beckman Analysers in Zonal Processing Laboratories.

Revenue: ₹156.91Cr as on June 2024 (Q2 24)
Net Profit: ₹23.94Cr as on June 2024 (Q2 24)
Listing date: 09 May, 2016
Chairperson Name: Rahul Guha
OrganisationThyrocare Technologies Ltd
HeadquartersNavi Mumbai
IndustryHealthcare
E-voting on sharesClick here to vote

Futures and Options

View the latest movement in Thyrocare Technologies Ltd Futures & Options, including strike prices, expiry dates, and percentage changes.

FAQs

What is Thyrocare Technologies Ltd price today?

Thyrocare Technologies Ltd share price today stands at ₹890.25, Open: ₹893.15, Previous Close: ₹912.1, High: ₹919, Low: ₹884.05, 52 Week High: ₹1055, 52 Week Low: ₹571.4.

How to Buy Thyrocare Technologies Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Thyrocare Technologies Ltd shares

What are today's traded volumes of Thyrocare Technologies Ltd?

Today's traded volume of Thyrocare Technologies Ltd(THYROCARE) is 1.15L.

What is today's market capitalisation of Thyrocare Technologies Ltd?

Today's market capitalisation of Thyrocare Technologies Ltd(THYROCARE) is ₹3,718.29 Cr.

What is the 52 Week High and Low Range of Thyrocare Technologies Ltd?

Thyrocare Technologies Ltd (THYROCARE)
Price
52 Week High
₹1055
52 Week Low
₹571.4

How much percentage Thyrocare Technologies Ltd is down from its 52 Week High?

Thyrocare Technologies Ltd (THYROCARE) share price is ₹890.25. It is down -15.62% from its 52 Week High price of ₹1055

How much percentage Thyrocare Technologies Ltd is up from its 52 Week low?

Thyrocare Technologies Ltd (THYROCARE) share price is ₹890.25. It is up 55.80% from its 52 Week Low price of ₹571.4